Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Mallinckrodt
UBS
Harvard Business School
Teva
Chubb
Express Scripts
Moodys
Accenture
Deloitte

Generated: October 21, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,239,173

« Back to Dashboard

Summary for Patent: 6,239,173

Title: 3-phenyl-4-(4(methylsulfonyl)phenyl)-2-(5H)-furanone as a cox-2 inhibitor
Abstract:The invention encompasses the novel compound of Formula I useful in the treatment of cyclooxygenase-2 mediated diseases. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.
Inventor(s): Wang; Zhaoyin (Pierrefond, CA), Therien; Michel (Laval, CA)
Assignee: Merck Frosst Canada Inc./Merck Frosst Canada & Co. (Kirkland, CA)
Application Number:09/443,000
Patent Claim Types:
see list of patent claims
Compound; Use; Composition;

No matches for this query

International Patent Family for Patent: 6,239,173

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria165825► Subscribe
Austria212343► Subscribe
Australia1269495► Subscribe
Australia1913297► Subscribe
Australia3613995► Subscribe
Australia5621594► Subscribe
Australia6197096► Subscribe
Australia691119► Subscribe
Australia6967494► Subscribe
Australia711902► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Colorcon
QuintilesIMS
Boehringer Ingelheim
Healthtrust
Farmers Insurance
Citi
Teva
Covington
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot